Nature · 2014
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A.
Show affiliations
- Tumeh PC — 1] University of California Los Angeles (UCLA), Los Angeles, California 90095, USA [2] Jonsson Comprehensive Cancer Center, Los Angeles, California 90095, USA.
- Harview CL — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Yearley JH — Merck &Co, Palo Alto, California 94304, USA.
- Shintaku IP — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Taylor EJ — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Robert L — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Chmielowski B — 1] University of California Los Angeles (UCLA), Los Angeles, California 90095, USA [2] Jonsson Comprehensive Cancer Center, Los Angeles, California 90095, USA.
- Spasic M — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Henry G — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Ciobanu V — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- West AN — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Carmona M — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Kivork C — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Seja E — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Cherry G — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Gutierrez AJ — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Grogan TR — University of California Los Angeles (UCLA), Los Angeles, California 90095, USA.
- Mateus C — Gustave Roussy and INSERM U981, Villejuif, Paris Sud, France.
- Tomasic G — Gustave Roussy and INSERM U981, Villejuif, Paris Sud, France.
- Glaspy JA — 1] University of California Los Angeles (UCLA), Los Angeles, California 90095, USA [2] Jonsson Comprehensive Cancer Center, Los Angeles, California 90095, USA.
- Emerson RO — Adaptive Biotechnologies, Seattle, Washington 98102, USA.
- Robins H — 1] Adaptive Biotechnologies, Seattle, Washington 98102, USA [2] Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
- Pierce RH — Merck &Co, Palo Alto, California 94304, USA.
- Elashoff DA — 1] University of California Los Angeles (UCLA), Los Angeles, California 90095, USA [2] Jonsson Comprehensive Cancer Center, Los Angeles, California 90095, USA.
- Robert C — Gustave Roussy and INSERM U981, Villejuif, Paris Sud, France.
- Ribas A — 1] University of California Los Angeles (UCLA), Los Angeles, California 90095, USA [2] Jonsson Comprehensive Cancer Center, Los Angeles, California 90095, USA.
49 read6 want to readRigor 2.9Novelty 2.9Impact 3.3Reprod. 3.3
Most-cited papers citing this
- Nat Commun · 2025 · cited by 4
- Nat Rev Cancer · 2026 · cited by 2
- J Immunother Cancer · 2025 · cited by 2
- Nat Commun · 2026 · cited by 1
- Cancer Cell Int · 2026 · cited by 1
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0
0
0
0
0
0
0
0
0